A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients

Clinical trial NCT01874028 · COMPLETED

Trial details

NCT number: NCT01874028
Sponsor: Univar BV
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Wilson's Disease

Start date: 2013-05-01
Primary completion: 2014-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.